Azintuxizumab
Product Specifications
CAS Number
1826819-57-1
Target
ADC Antibody, TNF
Related Pathways
Apoptosis, Antibody-drug Conjugate/ADC Related
Purity
0.976
Bioactivity
Azintuxizumab, an IgG4 bispecific antibody, is designed to specifically recognize and bind to the B-cell maturation antigen (BCMA), a molecular marker associated with plasma cell malignancies. Azintuxizumab shows significant promise in preclinical and translational research investigating therapeutic interventions for relapsed or refractory multiple myeloma (RRMM), thereby providing a dual-targeted mechanism of action for antibody-based immunotherapy.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog